MYX Mayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-up Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets this week, with company value as much as -33% lower @ today down to $4.34 a share after opening Week 21 at $6.48 @ on second thoughts from Cosette.Listen to the HotCopper podcast for in-depth discussions and insights on all the... Isaac McIntyre 22 May 2025 15:23 (AEST) ASX News Healthcare Drug Manufacturers - Specialty & Generic
ACR Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation Acrux Ltd has achieved the fourth approval from the US FDA, with its Nitroglycerin Ointment 0.4%, ready for commercialisation Caroline Smith 13 Dec 2024 14:58 (AEDT) ASX News Healthcare Drug Manufacturers - Specialty & Generic
